ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
72
Frequently Asked Questions
What is Market Cap of Alx Oncology Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alx Oncology Holdings Inc market cap is $436.08M.
What is the 52-week high for Alx Oncology Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alx Oncology Holdings Inc 52 week high is $17.83 as of June 05, 2024.
What is the 52-week low for Alx Oncology Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alx Oncology Holdings Inc 52 week low is $3.94 as of June 05, 2024.
What is Alx Oncology Holdings Inc stock price today?
Alx Oncology Holdings Inc stock price today is $8.80.
What was Alx Oncology Holdings Inc stock price yesterday?
Alx Oncology Holdings Inc stock price yesterday was $8.37.
What is the PE ratio of Alx Oncology Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alx Oncology Holdings Inc’s P/E ratio is -2.25.
What is the Price-to-Book ratio of Alx Oncology Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alx Oncology Holdings Inc P/B ratio is 2.5629.
What is Alx Oncology Holdings Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Alx Oncology Holdings Inc's EBITDA is -2.39.
What is the 50-day moving average of Alx Oncology Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alx Oncology Holdings Inc 50-day moving average is $13.84.
How many employess does Alx Oncology Holdings Inc has?